This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (12)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Effectiveness in Controlling Psychotic Behavior

WILLIAM APPLETON, MD

Arch Gen Psychiatry. 1963;9(6):586-592.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

I. Introduction

In the decade since its introduction into clinical psychiatry, chlorpromazine has become established as a major modality in the treatment of psychoses. Although the major parameters of its clinical use are agreed upon, matters of dosage are still uncertain, particularly the value of high dose schedules. One feature of its clinical pharmacology which contributes to its usefulness is the relatively wide range of safety. While most investigators report prescribing daily dosages of 300 to 800 mg in schizophrenia, some have used as much as 5,000 mg daily. The amount an individual prescribed is highly variable, limited by clinical effectiveness or the appearance of toxic signs.

At the Massachusetts Mental Health Center (formerly Boston Psychopathic Hospital) over a two-year period, one in every 12 patients treated with chlorpromazine received 1,500 mg or more daily at some time during their hospitalization. Because such . . . [Full Text PDF of this Article]

Author Affiliations
BOSTON

Resident in Psychiatry, Massachusetts Mental Health Center, and Teaching Fellow in Psychiatry, Harvard Medical School.

Footnotes
Submitted for publication May 31, 1963.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?